Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer

BACKGROUND: Previous data from our institution showed that hypofractionated thoracic radiotherapy (HypoTRT) with concurrent etoposide/platinum chemotherapy yielded favorable survival in patients with limited-stage small cell lung cancer (LS-SCLC). The present study retrospectively compared the survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Fan, Min, Liu, Di, Zhao, Kuai-Le, Wu, Kai-Liang, Zhao, Wei-Xin, Zhu, Zheng-Fei, Fu, Xiao-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346226/
https://www.ncbi.nlm.nih.gov/pubmed/28283034
http://dx.doi.org/10.1186/s13014-017-0788-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346226/
https://www.ncbi.nlm.nih.gov/pubmed/28283034
http://dx.doi.org/10.1186/s13014-017-0788-x

Ejemplares similares